Dr. Mark Sherrid, a nationally known hypertrophic cardiomyopathy expert and Director of the HCM Program at New York University Medical Center in New York City, presents on the treatment options for patients presenting with obstructive or non-obstructive hypertrophic cardiomyopathy. Hypertrophic cardiomyopathy (HCM) is a complex cardiac disease marked by thickening of the heart muscle that occurs without clinical cause.
The disease affects individuals differently, with different degrees of muscular wall thickening and a variety of symptoms. Patients may experience shortness of breath, exercise intolerance, chest pressure or pain, fainting, or no symptoms at all. In unusual cases HCM can cause sudden cardiac death.
The disease affects individuals differently, with different degrees of muscular wall thickening and a variety of symptoms. Patients may experience shortness of breath, exercise intolerance, chest pressure or pain, fainting, or no symptoms at all. In unusual cases HCM can cause sudden cardiac death.
Reviews
Be the first to review Hypertrophic Cardiomyopathy Program.
Write a Review
